Advocacy In Action: Who Should Have Molecular Testing When Diagnosed With Lung Cancer?

vitaloptions has 475 videos Subscribe Here

Description: Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing.

This segment asks the question: Why are only EFR and ALK are tested for and who should be tested?

Joining Selma Schimmel as co-moderators are:

David R. Spigel, MD - Director, Lung Cancer Research Program at Sarah Cannon Research Institute and a Medical Oncologist at Tennessee Oncology, PLLC, Nashville, TN

Ming S. Tsao, MD, FRCPC - Princess Margaret Cancer Centre, Toronto, Canada

Susan Mantel - VP Programs & Marketing, LUNGevity

Kim Norris - Founder/President, Lung Cancer Foundation of America

Regina Vidaver, PhD - Executive Director, National Lung Cancer Partnership
Shared By : vitaloptions
Posted on : 07/09/13
Added : 6 years ago
Category : General

More From vitaloptions

Nothing found.